Y mAbs Therapeutics (YMAB) Insider Trading
- $20,618,215.91
- $60,561,376.55
- Sept. 16, 2024
- Thomas Gad
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 13, 2020 | Chairman | 4,000 | $30.90 | Sell | $123,600.00 | |
| Dec. 16, 2019 | Chairman | 4,000 | $31.54 | Sell | $126,160.00 | |
| Dec. 2, 2019 | Chairman | 4,000 | $32.48 | Sell | $129,920.00 | |
| Nov. 18, 2019 | Chairman | 4,000 | $28.85 | Sell | $115,400.00 | |
| Nov. 4, 2019 | Chairman | 4,000 | $30.01 | Sell | $120,040.00 | |
| Oct. 30, 2019 | Director | 90,000 | $29.79 | Buy | $2,681,100.00 | |
| Oct. 21, 2019 | Chairman | 4,000 | $31.65 | Sell | $126,600.00 | |
| Oct. 18, 2019 | CEO | 7,250 | $16.71 | Sell | $121,147.50 | |
| Oct. 7, 2019 | Chairman | 4,000 | $25.21 | Sell | $100,840.00 | |
| Sept. 16, 2019 | Chairman | 4,000 | $30.59 | Sell | $122,360.00 | |
| Sept. 6, 2019 | Director | 17,243 | $27.00 | Sell | $465,561.00 | |
| Sept. 3, 2019 | Chairman | 4,000 | $25.77 | Sell | $103,080.00 | |
| Aug. 30, 2019 | Director | 89,166 | $26.58 | Sell | $2,370,032.28 | |
| Aug. 28, 2019 | Director | 49,357 | $27.08 | Sell | $1,336,587.56 | |
| Aug. 21, 2019 | Director | 168,244 | $27.57 | Sell | $4,638,487.08 | |
| Aug. 19, 2019 | Insider | 4,000 | $27.70 | Sell | $110,800.00 | |
| Aug. 5, 2019 | Insider | 4,000 | $21.78 | Sell | $87,120.00 | |
| July 22, 2019 | Insider | 4,000 | $22.54 | Sell | $90,160.00 | |
| July 8, 2019 | Insider | 4,000 | $22.40 | Sell | $89,600.00 | |
| June 24, 2019 | Insider | 4,000 | $21.77 | Sell | $87,080.00 | |
| June 10, 2019 | Insider | 4,000 | $22.79 | Sell | $91,160.00 | |
| June 3, 2019 | Insider | 4,000 | $20.03 | Sell | $80,120.00 | |
| May 28, 2019 | Insider | 6,000 | $20.21 | Sell | $121,260.00 | |
| May 13, 2019 | Insider | 6,000 | $20.61 | Sell | $123,660.00 | |
| April 11, 2019 | Insider | 250,000 | $25.89 | Sell | $6,472,500.00 | |
| Sept. 25, 2018 | CEO | 31,250 | $16.00 | Buy | $500,000.00 | |
| Sept. 25, 2018 | Director | 430,174 | $16.00 | Buy | $6,882,784.00 | |
| Sept. 21, 2018 | Director | 500,000 | $16.00 | Buy | $8,000,000.00 |
Insiders are both buying and selling Y mAbs Therapeutics stock.
The insider traders at Y mAbs Therapeutics are: Thomas Gad, Bo Kruse, Johan Wedell-Wedellsborg, Biotech Aps Wg, Vignesh Rajah, Pedro Claus Juan Moller-San, Mahiuddin Ahmed, David N Gill, James Healy, Ashu Tyagi, Gerard Ber, Joris Wilms, and Moller San Pedro Claus Juan
The most active insider trader at Y mAbs Therapeutics is Thomas Gad with 74 trades.
Thomas Gad has sold the most Y mAbs Therapeutics stock with a total value of $32,757,585.26.
Ashu Tyagi has bought the most Y mAbs Therapeutics stock with a total value of $13,765,568.00.
The most recent insider trade for Y mAbs Therapeutics was on Sept. 16, 2024.
The single biggest insider buy for Y mAbs Therapeutics was from James Healy with a total value of $8,000,000.00 on Sept. 21, 2018.
The single biggest insider sell for Y mAbs Therapeutics was from Thomas Gad with a total value of $6,472,500.00 on April 11, 2019.